BPC-157: What the research actually shows
A plain-language summary of the current BPC-157 literature — mechanism of action, tissue repair signals, and what researchers should know before designing a protocol.
Overview
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It has become one of the most widely studied peptides in musculoskeletal and gut research, with a growing body of preclinical literature examining its role in soft-tissue repair.
Mechanism of action
Research suggests BPC-157 modulates the nitric oxide system and upregulates growth hormone receptor expression in tendon fibroblasts, accelerating the migration, proliferation, and survival of cells central to soft-tissue repair. It has also been shown to promote angiogenesis — the formation of new blood vessels — in injured tissue.
What the literature examines
- Tendon-to-bone healing in animal models
- Muscle crush injury recovery rates
- Gut barrier integrity under inflammatory stress
- Ligament and soft-tissue collagen synthesis
Research considerations
Most published BPC-157 research is preclinical. Human clinical data remains limited, which is why Quantum Labs supplies all compounds as research-grade material — not for human consumption. Every batch is independently verified against a ≥98% purity specification to ensure reproducibility across research protocols.